PT  - JOURNAL ARTICLE
AU  - Glover, Crystal M.
AU  - Schneider, Julie A.
AU  - Bennett, David A.
AU  - Barnes, Lisa L.
AU  - Marquez, David X.
AU  - Aggarwal, Neelum T.
AU  - Leurgans, Sue
AU  - Graham, Karen L.
AU  - Frick, Susan
AU  - Shah, Raj C.
TI  - The NGAGE Model Developed at the Rush Alzheimer’s Disease Research Center: An Approach to Community Engagement and Inclusion in Dementia Research with Diverse Community-Dwelling Older Adults
AID  - 10.1101/2024.10.31.24316461
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.10.31.24316461
4099  - http://medrxiv.org/content/early/2024/11/04/2024.10.31.24316461.short
4100  - http://medrxiv.org/content/early/2024/11/04/2024.10.31.24316461.full
AB  - Background One of the biggest challenges in the field of Alzheimer’s disease and related dementias (ADRD) is the severe inequitable inclusion of Black and Latino adults in clinical research studies. Despite consistent and persistent efforts, rates of participation among diverse older adults remain critically low.Objective The purpose of this paper is to set forth The NGAGE Model, one developed at the Rush Alzheimer’s Disease Research Center (Rush ADRC) to facilitate community engagement and research participation among diverse older adults.Methods The NGAGE Model consists of five steps that are conceptually distinct but overlapping in practice: 1) Networking, 2) Give first, 3) Advocate for research, 4) Give back, and 5) Evaluate. We define and describe each step. For steps 1 through 4, we calculated the number of events, number of attendees for each event, and percentages of attendees by racial and ethnic categorizations annually from July 1, 2011, through June 30, 2023, resulting in data for 12 distinct years, as provided in annual progress reports to the National Institute on Aging. For Step 5, we counted the number of persons and computed percentages of people by racial and ethnic groups who consented to our Data and Specimen Repository and enrolled in a research study.Results Over 12 years, the Rush ADRC conducted 5,362 events with 265,794 attendees. Give First activities represented the NGAGE step with both the highest number of events (n=2,247) and the most attendees (n=124,403). Among Black adults, the highest attendee percentage existed for Advocate for Research events (47%), while the highest for Latinos occurred for Give First activities (26%). Furthermore, 2,135 persons consented to the Data and Specimen Repository and 5,905 enrolled in a research study across 12 years. Higher percentages of both Black (37%) and Latino (10%) adults enrolled in research studies compared to the Repository with 21% and 7%, respectively.Conclusions The NGAGE Model facilitated community engagement and research inclusion among Black and Latino adults, particularly via Give First and Advocate for Research activities. We discuss the impacts of study milestones, staff resources, and the COVID-19 pandemic on The NGAGE Model activities and outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Institute on Aging [grant numbers: P30AG072975 and P30AG010161 to JAS; R01AG022018 to LLB; R01AG17917 to DAB], the Illinois Department of Public Health, and the National Center for the Advancement of Translational Science [UL1TR002389].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:An Institutional Review Board of Rush University Medical Center gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. https://www.radc.rush.edu/